Literature DB >> 19926308

Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985-2004).

Jonathan H Lee1, Kimberly D Burner, Michael E Fealey, William D Edwards, Henry D Tazelaar, Thomas A Orszulak, Alan J Wright, Larry M Baddour.   

Abstract

BACKGROUND: Few studies have documented the clinicopathological features of prosthetic valve endocarditis independently of native valve endocarditis. STUDY
DESIGN: Retrospective analysis of patients undergoing cardiac surgery for prosthetic valve endocarditis at our institution (1985-2004).
METHODS: Medical records and microscopic slides were reviewed from 116 patients for demographics, infecting organisms, comorbidities, and pathologic features.
RESULTS: Patients were 12-86 years old (mean, 59 years). Among 122 valves, 64% were from men and 67% were purely regurgitant. Aortic prosthetic valve endocarditis frequently affected men (76%); mitral prosthetic valve endocarditis often affected women (62%). Embolization occurred in 35% and heart failure in 32%. Prevalent predisposing conditions were the prosthetic valve alone (43%) and diabetes mellitus (20%). Prosthetic valve endocarditis was aortic or mitral in 98% and was active in 70%. Annular abscess or paravalvular leak affected mechanical valves more frequently than bioprosthetic (89% vs. 65%; P=.001). Causative organisms (n=116) included Staphylococcus aureus (30%), coagulase-negative staphylococcus (22%), viridans streptococci (18%), enterococci (10%), other streptococci (8%), and other organisms (12%). S. aureus was the most prevalent cause of early-onset (38%) and late-onset (30%) prosthetic valve endocarditis. Coagulase-negative staphylococcus caused early-onset (31%) and most intermediate-onset (40%) disease and had a shorter median implantation-to-infection time than other organisms (6.5 vs. 61.3 months; P<.001). Viridans streptococci and enterococci primarily caused late-onset endocarditis. For active infections by cocci, most cases exhibited strong Gram staining, but four showed only strong Grocott methenamine silver staining.
CONCLUSIONS: Cocci accounted for 83% of infections. Early-onset prosthetic valve endocarditis was primarily staphylococcal, and late-onset prosthetic valve endocarditis resembled native valve endocarditis. Both Gram and Grocott methenamine silver stains were necessary to reliably identify organisms microscopically.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 19926308     DOI: 10.1016/j.carpath.2009.09.006

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  8 in total

1.  Guidelines enforcement and clinical outcome.

Authors:  Donato Santovito; Leopoldo Di Iorio; Chiara Mammarella; Enza Di Lembo; Camilla Paganelli; Andrea Mezzetti; Francesco Cipollone
Journal:  Intern Emerg Med       Date:  2013-01-22       Impact factor: 3.397

2.  Recent progress in the understanding of infective endocarditis.

Authors:  Andrew Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

3.  More Than Meets the Eye: Infective Endocarditis Presenting as Endogenous Endophthalmitis.

Authors:  Ricardo J Villasmil; Natalia Lattanzio; Katherine Burns; Talal Alkayali
Journal:  Cureus       Date:  2021-04-28

4.  Outcomes of Reoperative Valve Replacement in Patients with Prosthetic Valve Endocarditis: A 20-Year Experience.

Authors:  Young Woong Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee; Joon Bum Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-02-05

5.  Normal Values of the Mitral-Aortic Intervalvular Fibrosa Thickness: A Multimodality Study.

Authors:  Alberto Cresti; Pasquale Baratta; Francesco De Sensi; Marco Solari; Bruno Sposato; Stefano Minelli; Nevada Cioffi; Luca Franci; M Scalese; Ugo Limbruno
Journal:  J Cardiovasc Echogr       Date:  2019 Jul-Sep

6.  The Gerbode defect: a case series.

Authors:  Nicholas Sunderland; Ahmed El-Medany; Justin Temporal; Laura Pannell; Gemina Doolub; Martin Nelson; Hunaid Vohra
Journal:  Eur Heart J Case Rep       Date:  2021-01-12

Review 7.  Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All.

Authors:  Ryan Kean; Christopher Delaney; Ranjith Rajendran; Leighann Sherry; Rebecca Metcalfe; Rachael Thomas; William McLean; Craig Williams; Gordon Ramage
Journal:  J Fungi (Basel)       Date:  2018-01-15

8.  Advances in medicine and positive natural selection: Prosthetic valve endocarditis due to biofilm producer Micrococcus luteus.

Authors:  Guillermo Rodriguez-Nava; Abdelnasir Mohamed; Maria Adriana Yanez-Bello; Daniela Patricia Trelles-Garcia
Journal:  IDCases       Date:  2020-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.